Correlation Between Extraocular Muscle Enlargement and Thyroid Autoantibodies in Thyroid Eye Disease

Overview

Journal Jpn J Ophthalmol

Specialty Ophthalmology

Date 2024 Apr 12

PMID 38609717

Authors

Takahiro Koizumi

Takahiro Tanaka

Kazuki Umeda

Daisuke Komiyama

Hiroto Obata

Affiliations

Soon will be listed here.

Abstract

Purpose: This study aimed to investigate the factors affecting extraocular muscle enlargement in thyroid eye disease (TED).

Study Design: Retrospective study.

Methods: The thyroid-stimulating hormone (TSH) receptor antibody (TRAb), thyroid-stimulating antibody (TSAb), antithyroid peroxidase antibody (ATPO), and antithyroglobulin antibody (ATG) levels in patients diagnosed with TED who underwent orbital magnetic resonance imaging were assessed. The control group comprised the contralateral eye of patients who underwent orbital magnetic resonance imaging (MRI) for unilateral eyelid tumors or orbital disease. The thickness of the bilateral rectus muscles and superior oblique muscles was measured on orbital MRI. Muscle enlargement was classified as unilateral/bilateral and symmetric/asymmetric. The effects of age, sex, smoking history, TSH, thyroid hormone, and thyroid autoantibodies on the muscle thickness and number of enlarged muscles were assessed by use of simple and multiple regression analyses.

Results: The TED and control groups comprised 41 and 44 cases, respectively. The positivity rate of TSAb in patients with TED was 92.7% higher than that of the other autoantibodies. Muscle enlargement was observed in 29 of the 41 cases (70.7%). Older age and higher TSAb levels were identified as significant factors affecting the total muscle thickness and number of enlarged muscles. Bilateral muscle enlargement and asymmetrical muscle enlargement were observed in 17 (58.6%) and 23 (79.3%) of the 29 cases, respectively. The TSAb levels and age had no significant effect on the type of muscle enlargement.

Conclusions: TSAb showed significant associations with extraocular muscle enlargement. Measurement of TSAb, rather than of TRAb, may be more useful for diagnosing extraocular muscle enlargement in patients with TED.

References

Seo S, Sanchez Robledo M . Usefulness of TSH receptor antibodies as biomarkers for Graves' ophthalmopathy: a systematic review. J Endocrinol Invest. 2018; 41(12):1457-1468. DOI: 10.1007/s40618-018-0945-6. View

Higashiyama T, Nishida Y, Ohji M . Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy. Clin Ophthalmol. 2016; 10:721-9. PMC: 4844430. DOI: 10.2147/OPTH.S105096. View

Kavoussi S, Giacometti J, Servat J, Levin F . The relationship between sex and symmetry in thyroid eye disease. Clin Ophthalmol. 2014; 8:1295-300. PMC: 4096447. DOI: 10.2147/OPTH.S61041. View

Tian S, Nishida Y, Isberg B, Lennerstrand G . MRI measurements of normal extraocular muscles and other orbital structures. Graefes Arch Clin Exp Ophthalmol. 2000; 238(5):393-404. DOI: 10.1007/s004170050370. View

Kashkouli M, Kaghazkanani R, Heidari I, Ketabi N, Jam S, Azarnia S . Bilateral versus unilateral thyroid eye disease. Indian J Ophthalmol. 2011; 59(5):363-6. PMC: 3159317. DOI: 10.4103/0301-4738.83612. View

Shen S, Fong K, Wong H, Looi A, Chan L, Rootman J . Normative measurements of the Chinese extraocular musculature by high-field magnetic resonance imaging. Invest Ophthalmol Vis Sci. 2009; 51(2):631-6. DOI: 10.1167/iovs.09-3614. View

Wang Y, Mettu P, Broadbent T, Radke P, Firl K, Shepherd 3rd J . Thyroid eye disease presenting with superior rectus/levator complex enlargement. Orbit. 2019; 39(1):5-12. DOI: 10.1080/01676830.2019.1594969. View

Kanda Y . Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2012; 48(3):452-8. PMC: 3590441. DOI: 10.1038/bmt.2012.244. View

Lacheta D, Miskiewicz P, Gluszko A, Nowicka G, Struga M, Kantor I . Immunological Aspects of Graves' Ophthalmopathy. Biomed Res Int. 2019; 2019:7453260. PMC: 6875285. DOI: 10.1155/2019/7453260. View

10.

Villadolid M, Yokoyama N, Izumi M, Nishikawa T, Kimura H, Ashizawa K . Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance. J Clin Endocrinol Metab. 1995; 80(9):2830-3. DOI: 10.1210/jcem.80.9.7673432. View

11.

Choi J, Noh H, Kim Y, Woo K . Prognostic factors of restrictive myopathy in thyroid eye disease. Sci Rep. 2021; 11(1):13781. PMC: 8253730. DOI: 10.1038/s41598-021-93275-9. View

12.

Hiromatsu Y, Eguchi H, Tani J, Kasaoka M, Teshima Y . Graves' ophthalmopathy: epidemiology and natural history. Intern Med. 2014; 53(5):353-60. DOI: 10.2169/internalmedicine.53.1518. View

13.

El-Kaissi S, Bowden J, Henry M, Yeo M, Champion B, Brotchie P . Association between radioiodine therapy for Graves' hyperthyroidism and thyroid-associated ophthalmopathy. Int Ophthalmol. 2010; 30(4):397-405. DOI: 10.1007/s10792-010-9368-x. View

14.

Perros P, Zarkovic M, Panagiotou G, Azzolini C, Ayvaz G, Baldeschi L . Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre study. J Endocrinol Invest. 2020; 43(12):1717-1722. PMC: 7652741. DOI: 10.1007/s40618-020-01258-w. View

15.

Noh J, Hamada N, Inoue Y, Abe Y, Ito K . Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Thyroid. 2000; 10(9):809-13. DOI: 10.1089/thy.2000.10.809. View

16.

Zheng J, Duan H, You S, Liang B, Chen Y, Huang H . Research progress on the pathogenesis of Graves' ophthalmopathy: Based on immunity, noncoding RNA and exosomes. Front Immunol. 2022; 13:952954. PMC: 9445982. DOI: 10.3389/fimmu.2022.952954. View

17.

Szucs-Farkas Z, Toth J, Balazs E, Galuska L, Burman K, Karanyi Z . Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes?. AJR Am J Roentgenol. 2002; 179(4):1005-10. DOI: 10.2214/ajr.179.4.1791005. View

18.

Kvetny J, Puhakka K, Rohl L . Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis. Acta Ophthalmol Scand. 2006; 84(3):419-23. DOI: 10.1111/j.1600-0420.2005.00617.x. View

19.

Mukasa K, Yoshimura Noh J, Kouzaki A, Ohye H, Kunii Y, Watanabe N . TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients. Endocr J. 2015; 63(2):151-7. DOI: 10.1507/endocrj.EJ15-0137. View

20.

Ozgen A, Aydingoz U . Normative measurements of orbital structures using MRI. J Comput Assist Tomogr. 2000; 24(3):493-6. DOI: 10.1097/00004728-200005000-00025. View